Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions

Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

Demonstrating Clinical Utility Using a Validated Methodology From the Market Research Toolkit

admin.veranex : Mar 24, 2025 10:23:08 PM

Commercialization

Veranex Director Lauren Fusfeld uses a case study to show how conjoint analysis can demonstrate to payers and health care providers the clinical utility of a prognostic test. Lauren’s article is featured on page 30.

View Article

3 min read

Case Study: Optimizing Pricing Strategies for a Medical Device Product Family

admin.veranex : Mar 24, 2025 10:23:12 PM

Background A leading global medical device manufacturer faced a pricing strategy challenge and partnered with Veranex (formerly Boston...

Commercialization
Read More

Published Health Economics Study Shows a High Disease Burden Associated with Stress/Mixed Urinary Incontinence to U.S. Payers

admin.veranex : Mar 24, 2025 10:23:07 PM

Veranex’s Commercial Strategy and Market Access team members, Manasi Datar, PhD, Li-Chen Pan, MPH, and Thomas F. Goss, PharmD, along with...

Commercialization
Read More

Veranex Presents Study Results at the National Kidney Foundation Spring Clinical Meeting

admin.veranex : Mar 24, 2025 10:22:49 PM

Dr. Manasi Datar and colleagues used conjoint analysis to estimate preferences regarding kidney disease testing from 401 PCPs via a web survey....

Commercialization
Read More